The HF-HRV Registry

Boston Scientific

Status: Completed

Conditions: Arrhythmia; Heart Failure

Treatments: Device: Cardiac Resynchronization Therapy

Study type: Observational

Funder types: Industry

Identifiers

NCT00236236

CR-CA-022103-H

Details and patient eligibility

About

The Registry will evaluate how HRV Monitor diagnostics change after cardiac resynchronization therapy in patients with heart failure.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients receiving their first CRT-D
• Patients who sign and date a Patient Informed Consent prior to device implant
• Patients who are available and willing to attend follow-up visits at the study center in which they were enrolled

Exclusion criteria

• Patients who are anticipated to receive pacing modes other than DDD or VDD (i.e., chronic atrial fibrillation patients are excluded), or patients who are anticipated to receive adaptive rate therapy
• Patients who are younger than 18 years of age
• Patients whose life expectancy is less than six-months due to other medical conditions
• Patients with or who are likely to receive a tricuspid or other valve prosthesis
• Patients who are currently enrolled in another investigational study that would directly impact the treatment or outcome of the current study
• Women who are pregnant